Health Canada Issues Industrial Hemp License to CEPG, Future Farm’s Canadian Subsidiary

via NEWMEDIAWIRE -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (

CSE: FFT

) (

OTCQB: FFRMF

) is pleased to announce that its Canadian subsidiary, CEPG Consulting and Design Inc. (“CEPG”), has been issued an Industrial Hemp License from Health Canada. 

As previously announced in April, the Company hired consultant Gary Harnum to assist with several license applications to Health Canada. This particular license, in combination with a building permit previously issued by the City of St. John’s, Newfoundland, allows CEPG to move forward with the construction of its planned hemp research facility at 148 East White Hills Road.  

Another license application has been submitted to Health Canada as part of a potential collaboration between CEPG, Rahan Meristem (1998) LTD (“Rahan”) and The Memorial University of Newfoundland (“MUN”) to develop a research program for the characterization of elite Cannabis clones. 

“I am excited to get started on our long-anticipated hemp breeding program,” comments Chris Snellen, president and CEO of CEPG. “This License is one more step in the right direction, and we anticipate others to follow in the near future thanks in large part to the hard work and dedication of Mr. Harnum.” 

For further information about Future Farm Technologies, contact Investor Relations at [e-mail] or [phone] ext. 710. 

On behalf of the Board, 

Future Farm Technologies Inc. 

William Gildea, CEO 

About Future Farm Technologies Inc. 

Future Farm Technologies is a Canadian public company that is poised to be a leading supplier of hemp-derived CBD products to meet the burgeoning demand in the U.S. and global markets. The Company’s current key initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities throughout the U.S. and the development of elite strains of cannabis in Canada. 

Future Farm’s seasoned management team brings a deep understanding of operations and agriculture with the financial and regulatory expertise needed to become an industry leader in the evolving market for CBD and related compounds. 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions.  There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Investor Relations
888-387-3761 x10
[e-mail]